Wegovy obesity drug maker Novo Nordisk increases full year outlook
Sales and profit ahead of expectationsFull year outlook raisedWegovy demand outstripping supplyDanish pharmaceutical giant Novo Nordisk (NOVO-B:CPH), known for its leading weight-loss drug Wegovy, delivered better than expected...
02 May 2024